7 Liver Cancer Clinical Trials in Detroit, ME (2026)

Q: How do I join a clinical trial in Detroit?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you.

Recruiting Liver Cancer Studies in Detroit

NCT06084234Recruiting

National Liver Cancer Screening Trial

The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or pati...

Detroit, ME5,500 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06109272Recruiting

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading cause of cancer-related death. The majority of participants first presenting with HCC have advanced unresectable or metastatic...

Detroit, ME660 participantsAbbVie

View Study Details

NCT07118202Recruiting

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced hepatocellular carcinoma (HCC) who have no standard of care options can affect patients surviva...

Detroit, ME198 participantsBarbara Ann Karmanos Cancer Institute

View Study Details

NCT07291076Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

The purpose of this study is to evaluate the safety and tolerability of Pumitamig alone or in combination with Ipilimumab in participants with first-line advanced or unresectable Hepatocellular Carcin...

Detroit, ME198 participantsBristol-Myers Squibb

View Study Details

NCT05440708Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

The primary objectives of Cohort A Phase 1b are to evaluate the safety and tolerability of TTI-101 orally administered as a single agent to participants with locally advanced or metastatic, and unrese...

Detroit, ME193 participantsTvardi Therapeutics, Incorporated

View Study Details

NCT05727176Recruiting

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

This is an open-label, multinational, randomized Phase 2 study confirming the clinical benefit of 20 mg futibatinib and evaluating the safety and efficacy of 16 mg futibatinib in previously treated CC...

Detroit, ME120 participantsTaiho Oncology, Inc.

View Study Details

NCT06915753Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary antitumor activity of TYRA-430 in cancers with FGF/FGFR pathway aberrations, includin...

Detroit, ME100 participantsTyra Biosciences, Inc

View Study Details

About Liver Cancer Clinical Trials in Detroit

Liver cancer most commonly presents as hepatocellular carcinoma (HCC) and is often associated with chronic liver disease or hepatitis. It is one of the fastest-growing causes of cancer death. Treatment options include surgery, liver transplant, ablation, and systemic therapies.

There are currently 7 liver cancer clinical trials recruiting participants in Detroit, ME. These studies are seeking a combined 6,969 participants. Research is being sponsored by University of Texas Southwestern Medical Center, AbbVie, Barbara Ann Karmanos Cancer Institute and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Cancer Clinical Trials in Detroit — FAQ

Are there liver cancer clinical trials in Detroit?

Yes, there are 7 liver cancer clinical trials currently recruiting in Detroit, ME. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Detroit?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.

Are clinical trials in Detroit free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.

What liver cancer treatments are being tested?

The 7 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for liver cancer.

Data updated July 13, 2026 from ClinicalTrials.gov